The general objective of the iPAAC Joint Action (JA) is to develop innovative approaches to advances in cancer control. The innovation that will be covered within the JA consists of further development of cancer prevention, comprehensive approaches to the use of genomics in cancer control, cancer information and registries, improvements and challenges in cancer care, mapping of innovative cancer treatments and governance of integrated cancer control, including a new analysis of National Cancer Control Plans. The key focus of the Joint Action will be on implementation, as reflected in the key deliverable, i.e. the Roadmap on Implementation and Sustainability of Cancer Control Actions, which will support member states in the implementation of iPAAC and CANCON recommendations.
million EUR co-funding by EC
44 partners (Competent Authorities and Affiliated Entities)
20 May 2019
Lack of awareness is a major barrier to early cancer detection
Cancer experts across Europe declare that there are still significant barriers to detecting cancer early. Over 150 experts from over 30 countries responded to the survey of the EU co-funded Joint Action iPAAC (innovative Partnership for Action Against Cancer). The results were announced in Budapest today.
13 May 2019
Contest of Best Practices tackling social inequalities in cancer prevention
FISABIO launches the Contest of Best Practices tackling social inequalities in cancer prevention.
08 May 2019
Early Diagnosis of Cancer - 5 Things You Need to Know – REGISTRATION OPEN
The WP5 Conference Early Diagnosis of Cancer - 5 Things You Need to Know will take place on 20 May 2019 and will be hosted by the Hungarian National Institute of Oncology in Budapest. Registrations for the conference have been extended until 10 May!
16 Apr 2019
2nd iPAAC Joint Action meeting
The second iPAAC JA meeting was held on 10–11 April 2019 in Belgrade, Serbia.